During a Case-Based Roundtable® event, Tara K. Gregory, MD, discussed how to implement use of bispecific T-cell engagers in ...
The bispecific T-cell engager tarlatamab showed continued efficacy and tolerable safety, according to follow-up from the ...
The next-generation radiopharmaceutical ABD-147 was previously granted FDA fast track designation in extensive-stage small ...
As oncologists and the healthcare industry advance their practices to propel care for children, it is crucial for the ...
Panelists discuss how a case study illustrates the multisystem manifestations of chronic graft-versus-host disease and demonstrate the application of NIH organ-specific scoring for comprehensive ...
Panelists discuss how chronic graft-versus-host disease severity can be stratified to guide the tailoring of systemic treatments and supportive care strategies for optimal patient management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results